The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes major
challenges to the healthcare system. SARS-CoV-2 infection leads to millions of deaths …

ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

In cancer patients, thrombocytopenia can result from bone marrow infiltration or from
anticancer medications and represents an important limitation for the use of antithrombotic …

Aims The aim of this study is to evaluate temporal trends, treatment, and clinical outcomes of
patients who present with an acute myocardial infarction (AMI) and have a current or …

Cancer patients have an increased risk of cardiovascular disease and, notably, a significant
prevalence of acute coronary syndrome (ACS). It has been shown that an elevated presence …

Advances in treatment, common cardiovascular (CV) risk factors and the ageing of the
population have led to an increasing number of cancer patients presenting with acute CV …

Background: It is unknown to what extent the clinical benefits of PCI outweigh the risks and
costs in patients with vs. without cancer and within each cancer type. We performed the first …

Cancer patients have varying incidence, depth and duration of thrombocytopenia. The
mainstay of managing severe chemotherapy-induced thrombocytopenia (CIT) in cancer is …

Cardiologists are encountering a growing number of cancer patients with ischaemic heart
disease (IHD). Several factors account for the interrelationship between these two …

Introduction: There are numerous shared risk factors in the etiopathogenesis of coronary
artery disease (CAD) and cancer both at epidemiologic and molecular level. Additionally …